These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12935941)

  • 1. Pain and the blood-brain barrier: obstacles to drug delivery.
    Wolka AM; Huber JD; Davis TP
    Adv Drug Deliv Rev; 2003 Aug; 55(8):987-1006. PubMed ID: 12935941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System.
    Lochhead JJ; Ronaldson PT; Davis TP
    AAPS J; 2017 Jul; 19(4):910-920. PubMed ID: 28353217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The blood-brain barrier and drug delivery in the central nervous system].
    Loch-Neckel G; Koepp J
    Rev Neurol; 2010 Aug; 51(3):165-74. PubMed ID: 20645267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS drug delivery: opioid peptides and the blood-brain barrier.
    Witt KA; Davis TP
    AAPS J; 2006 Feb; 8(1):E76-88. PubMed ID: 16584136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous system.
    Van Bree JB; De Boer AG; Danhof M; Breimer DD
    Pharm World Sci; 1993 Feb; 15(1):2-9. PubMed ID: 8485503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory mediators and modulation of blood-brain barrier permeability.
    Abbott NJ
    Cell Mol Neurobiol; 2000 Apr; 20(2):131-47. PubMed ID: 10696506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.
    Patching SG
    Mol Neurobiol; 2017 Mar; 54(2):1046-1077. PubMed ID: 26801191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
    Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
    CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammatory pain and the neurovascular unit: a central role for glia in maintaining BBB integrity?
    Willis CL; Brooks TA; Davis TP
    Curr Pharm Des; 2008; 14(16):1625-43. PubMed ID: 18673205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the mechanism of enhancement of central nervous system delivery of 2'-beta-fluoro-2',3'-dideoxyinosine via a blood-brain barrier adenosine deaminase-activated prodrug.
    Johnson MD; Chen J; Anderson BD
    Drug Metab Dispos; 2002 Feb; 30(2):191-8. PubMed ID: 11792690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.
    Ronaldson PT; Davis TP
    Ther Deliv; 2011 Aug; 2(8):1015-41. PubMed ID: 22468221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood-brain barrier.
    Kim KT; Lee HS; Lee JJ; Park EK; Lee BS; Lee JY; Bae JS
    Future Med Chem; 2018 Nov; 10(22):2659-2674. PubMed ID: 30499740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier.
    Strazielle N; Ghersi-Egea JF
    Curr Pharm Des; 2016; 22(35):5463-5476. PubMed ID: 27464721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the RBE4 cell line to explore carrier-mediated drug delivery to the CNS via the L-system amino acid transporter at the blood-brain barrier.
    Reichel A; Abbott NJ; Begley DJ
    J Drug Target; 2002 Jun; 10(4):277-83. PubMed ID: 12164376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of nanotechnology in drug delivery to the central nervous system.
    Saeedi M; Eslamifar M; Khezri K; Dizaj SM
    Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell biology of the neurovascular unit: implications for drug delivery across the blood-brain barrier.
    McCarty JH
    Assay Drug Dev Technol; 2005 Feb; 3(1):89-95. PubMed ID: 15798399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the Blood to the Central Nervous System: A Nanoparticle's Journey Through the Blood-Brain Barrier by Transcytosis.
    Fullstone G; Nyberg S; Tian X; Battaglia G
    Int Rev Neurobiol; 2016; 130():41-72. PubMed ID: 27678174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug targeting to the brain.
    de Boer AG; Gaillard PJ
    Annu Rev Pharmacol Toxicol; 2007; 47():323-55. PubMed ID: 16961459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel drug-delivery approaches to the blood-brain barrier.
    Wang X; Yu X; Vaughan W; Liu M; Guan Y
    Neurosci Bull; 2015 Apr; 31(2):257-64. PubMed ID: 25595370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review.
    Bicker J; Alves G; Fortuna A; Falcão A
    Eur J Pharm Biopharm; 2014 Aug; 87(3):409-32. PubMed ID: 24686194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.